Metzger J Y, Berthou V, Perrin P, Sichel J P
Centre Psychothérapique, Hôpitaux Civils de Colmar.
Encephale. 1998 Sep-Oct;24(5):480-5.
The concept of seasonal periodicity in psychiatry has been studied for thirty years in different domains, particularly in that affective disorders. It seems to be established that winter seasonal depressions are correlated to a particular vulnerability to the decrease in ambient light; this led directly to the development of phototherapy as primary treatment of SAD, simultaneously to the development of the clinical concept. Since the first demonstration by Rosenthal of the efficacy of phototherapy in SAD, numerous studies have confirmed that bright light provides rapid and effective treatment for this type of disorder. Phototherapy has been used at the Centre Psychothérapique des Hôpitaux Civils de Colmar for five years in three ways: as an alternative treatment to medication, in addition to antidepressive medication, and as primary treatment of seasonal depression. We describe the evaluation protocol of this treatment, which was established in collaboration with the Psychiatric Clinic of the University of Basel. The principal inclusion criterion for this study was the presence or regular phases of depression or loss of energy in autumn and winter; the regularity of the appearance of symptoms in winter was predominant over the severity of the symptoms, their seasonal occurrence being the most important predictive factor in favour of phototherapy. Our prospective study enabled us to include, over a period of two years, 18 subjects presenting very different symptomatology. Though the sample was heterogeneous, the results of treatment efficacy are satisfactory: we note effectively a decrease of 67.5% in the modified Hamilton scale even though strict criteria for seasonality (Seasonal Screening Questionary, Rosenthal's Criteria) were not always respected. These data should lead us to widen the indication for phototherapy, particularly in patients presenting mood disorders which are not exclusively seasonal, and support the accumulating experimental data for the selective antidepressive effect of light.
精神病学中季节性周期性的概念在不同领域已经研究了三十年,尤其是在情感障碍方面。似乎已经确定冬季季节性抑郁症与对环境光减少的特定易感性相关;这直接导致了光疗法作为季节性情感障碍(SAD)主要治疗方法的发展,同时也推动了临床概念的发展。自罗森塔尔首次证明光疗法对SAD有效以来,大量研究证实强光可为这类疾病提供快速有效的治疗。在科尔马市立医院心理治疗中心,光疗法已经以三种方式使用了五年:作为药物治疗的替代疗法、作为抗抑郁药物的辅助疗法以及作为季节性抑郁症的主要治疗方法。我们描述了与巴塞尔大学精神病诊所合作制定的这种治疗方法的评估方案。本研究的主要纳入标准是在秋冬季节存在抑郁或精力丧失的定期发作阶段;冬季症状出现的规律性比症状的严重程度更为重要,症状的季节性发作是支持光疗法的最重要预测因素。我们的前瞻性研究使我们在两年时间里纳入了18名症状差异很大的受试者。尽管样本具有异质性,但治疗效果的结果令人满意:我们实际上注意到改良汉密尔顿量表得分下降了67.5%,尽管并非总是严格遵循季节性的标准(季节性筛查问卷,罗森塔尔标准)。这些数据应促使我们扩大光疗法的适应症,特别是对于那些并非仅为季节性的情绪障碍患者,并支持关于光的选择性抗抑郁作用的越来越多的实验数据。